<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">vasculitides</z:e> are a group of disorders that include the <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> group of systemic necrotizing <z:e sem="disease" ids="C0151436" disease_type="Disease or Syndrome" abbrv="">vasculitides, hypersensitivity</z:e> <z:hpo ids='HP_0002633'>vasculitis</z:hpo>, Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>, lymphomatoid <z:hpo ids='HP_0002955'>granulomatosis</z:hpo>, giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo>, <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease, and isolated <z:mp ids='MP_0001864'>angiitis</z:mp> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="1" pm="."><plain>Classification is based on clinical, angiographic, and histological features </plain></SENT>
<SENT sid="2" pm="."><plain>The frequency and distribution of neurological involvement vary with the underlying disorder and may provide the initial symptoms </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">Polyarteritis nodosa</z:e> and Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> may affect both the central and peripheral <z:mp ids='MP_0008912'>nervous</z:mp> systems, whereas isolated <z:mp ids='MP_0001864'>angiitis</z:mp> of the central <z:mp ids='MP_0008912'>nervous</z:mp> system and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease affect the central <z:mp ids='MP_0008912'>nervous</z:mp> system alone </plain></SENT>
<SENT sid="4" pm="."><plain>Neurological dysfunction occurs in 80% of patients with <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> and fewer than 10% of patients with hypersensitivity <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanism of neurological dysfunction in the <z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">vasculitides</z:e> is tissue <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The clinical effects of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> vary, and symptoms may be transient or prolonged </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0151295" disease_type="Disease or Syndrome" abbrv="">Mononeuritis multiplex</z:e>, <z:hpo ids='HP_0001271'>polyneuropathy</z:hpo>, and <z:hpo ids='HP_0001297'>stroke</z:hpo> are frequent complications, but <z:hpo ids='HP_0001298'>encephalopathies</z:hpo>, <z:e sem="disease" ids="C0010266" disease_type="Disease or Syndrome" abbrv="">cranial neuropathies</z:e>, and <z:e sem="disease" ids="C0700251" disease_type="Disease or Syndrome" abbrv="">brachial plexopathies</z:e> are seen as well </plain></SENT>
<SENT sid="8" pm="."><plain>The occurrence of symptoms late in the course of a disease suggests <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> resulting from healed, scarred vessels as well as from those that are acutely inflamed; this is the case in <z:e sem="disease" ids="C0039263" disease_type="Disease or Syndrome" abbrv="">Takayasu</z:e>'s <z:hpo ids='HP_0012089'>arteritis</z:hpo> and possibly also in <z:e sem="disease" ids="C0031036" disease_type="Disease or Syndrome" abbrv="">polyarteritis nodosa</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment is based on identifying and removing the sensitizing agent when possible </plain></SENT>
<SENT sid="10" pm="."><plain>Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> requires therapy with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>; temporal <z:hpo ids='HP_0012089'>arteritis</z:hpo>, with <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>In other <z:e sem="disease" ids="C0042384" disease_type="Disease or Syndrome" abbrv="">vasculitides</z:e> a balance must be reached between the progression of the disease and the side effects of immunosuppression </plain></SENT>
</text></document>